Minimal change disease risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
== Overview == | == Overview == | ||
The cause of minimal change disease has not been identified or idiopathic.Nephrotic syndrome is most commonly as a result of damage to the clusters of tiny blood vessels (glomeruli) . | The cause of minimal change disease has not been identified or idiopathic. Nephrotic syndrome is most commonly as a result of damage to the clusters of tiny blood vessels (glomeruli).B ut secondary causes may be due to Drugs, Toxins, Infection, and Tumor. | ||
== Common Causes == | == Common Causes == | ||
Revision as of 13:26, 4 June 2018
Overview
The cause of minimal change disease has not been identified or idiopathic. Nephrotic syndrome is most commonly as a result of damage to the clusters of tiny blood vessels (glomeruli).B ut secondary causes may be due to Drugs, Toxins, Infection, and Tumor.
Common Causes
Common risk factors in the development of minimal change disease include:[1]
- Children within the Age >1 year but <8 years
- Hodgkin lymphoma
- leukemia
- Recent viral illness
- Toxins like Mercury, bee stings, fire coral exposure are one of the causes for minimal change disease.
- Drugs like[2]
- Salazopyrin
- Mercury
- Tiopronin
- Lithium
- D-penicillamine
- Gold
- Tyrosine-kinase inhibitor
Less Common Causes
Less common causes of minimal change disease include:[3][4]
- Hepatitis B or C infection
- low birth weight (LBW)
- Hematopoietic stem cell transplantation
|
Minimal Change Disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Minimal change disease risk factors On the Web |
|
American Roentgen Ray Society Images of Minimal change disease risk factors |
|
Risk calculators and risk factors for Minimal change disease risk factors |
References
- ↑ Iijima, Kazumoto; Hamahira, Kiyoshi; Tanaka, Ryojiro; Kobayashi, Akiko; Nozu, Kandai; Nakamura, Hajime; Yoshikawa, Norishige (2002). "Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome". Kidney International. 61 (5): 1801–1805. doi:10.1046/j.1523-1755.2002.00303.x. ISSN 0085-2538.
- ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). "Minimal Change Disease". Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
- ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). "Minimal Change Disease". Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
- ↑ Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). "Minimal Change Disease". Clinical Journal of the American Society of Nephrology. 12 (2): 332–345. doi:10.2215/CJN.05000516. ISSN 1555-9041.